Proteasomes in Distal Myopathy with Rimmed Vacuoles

Internal Medicine

Volumn 37, Issue 9, 1998, Pages 746-752

  Kumamoto, Toshihide ^a   Fujimoto, Shin ^a   Nagao, Shin Ichiro ^a   Masuda, Tomoko ^a   Sugihara, Rie ^a   Ueyama, Hidetsugu ^a   Tsuda, Tomiyasu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Calpain; Cathepsins; Lysosome; Muscle degradation; Ubiquitin

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALPAIN; CYSTEINE PROTEINASE; MULTIENZYME COMPLEX; MUSCLE PROTEIN; PROTEASOME; UBIQUITIN;

ADULT; ARTICLE; BIOPSY; CELL VACUOLE; FEMALE; HUMAN; LYSOSOME; MALE; METABOLISM; MIDDLE AGED; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE DISEASE; PATHOLOGY; PHAGOCYTOSIS; PHYSIOLOGY; ULTRASTRUCTURE;

ADENOSINE TRIPHOSPHATE; ADULT; BIOPSY; CALPAIN; CYSTEINE ENDOPEPTIDASES; FEMALE; HUMANS; LYSOSOMES; MALE; MIDDLE AGED; MULTIENZYME COMPLEXES; MUSCLE FIBERS; MUSCLE PROTEINS; MUSCULAR ATROPHY; MUSCULAR DISEASES; PHAGOCYTOSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITINS; VACUOLES;

EID: 0032150412     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.746     Document Type: Article

References (26)

1. Fukuhara N, Kumamoto T, Tsubaki T. Rimmed vacuoles. Acta Neuropathol (Berl) 51: 229-235, 1980.
2. Kumamoto T, Fukuhara N, Nagashima M, Kanda T, Wakabayashi M. Distal myopathy: Histochernical and ultrastructural studies. Arch Neurol 39: 367-371, 1982.
3. Kumamoto T, Ueyama H, Watanabe S, Kominami E, Ando M. Muscle fiber degradation in distal myopathy with rimmed vacuoles. Acta Neuropathol (Berl) 87: 143-148, 1994.
4. Ii K, Hizawa K, Nonaka I, Sugita H, Kominami E, Katunuma N. Abnormal increases of lysosomal cysteinine proteinases in rimmed vacuoles in the skeletal muscle. Am J Pathol 122: 193-198, 1986.
5. Jimi T, Satoh Y, Takeda A, Shibuya S, Wakayama Y, Sugita K. Strong immunoreactivity of cathepsin L at the site of rimmed vacuoles in diseased muscles. Brain 115 Pt 1: 249-260, 1992.
6. Murakami N, Ihara Y, Nonaka I. Muscle fiber degeneration in distal myopathy with rimmed vacuole formation. Acta Neuropathol (Berl) 89: 29-34, 1995.
7. Askanas V, Engel WK, Mirabella M. Idiopathic inflammatory myopathies: Inclusion-body myositis. polymyositis, and dermatomyositis. Curr Opin Neurol 7: 448-456, 1994.
8. Tiao G, Pagan JM, Samuels N, et al. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRN A levels in rat skeletal muscle. J Clin Invest 94: 2255-2264, 1994.
9. Mitch WE, Goldberg AL. Mechanisms of muscle wasting: the role of the ubiquitin-proteasome pathway. N Engl J Med 335: 1897-1905, 1996.
10. Medina R, Wing SS, Goldberg AL. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J 307: 631-637, 1995.
11. Wing SS, Haas AL, Goldberg AL. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. Biochem J 307: 639-645, 1995.
12. Dahlmann B, Kuehn L. The 20S/26S proteasomal pathway of protein degradation in muscle tissue. Mol Biol Rep 21: 57-62, 1995.
13. Taylor RG, Tassy C, Briand M, Robert N, Briand Y, Ouali A. Proteolytic activity of proteasome on myofibrillar structures. Mol Biol Rep 21: 71-73, 1995.
14. 2+-activated. and ubiquitin-proteasome proteolytic pathways. J Clin Invest 97: 1610-1617, 1996.
15. Tanaka K, Ii K, Ichihara A, Waxman L, Goldberg AL. A high molecular weight protease in the cytosol of rat liver. I. Purification, enzymological properties, and tissue distribution. J Biol Chem 261: 15197-15203, 1986.
16. Beyette JR, Mykles DL. Immunocytochemical localization of the multicatalytic proteinase (proteasome) in crustacean striated muscles. Muscle Nerve 15: 1023-1035, 1992.
17. Peters J-M, Franke WW, Kleinschmidt JA. Distinct 19 S and 20 S subcomplexes ot the 26 S proteasome and their distribution in the nucleus and the cytoplasm. J Biol Chem 269: 7709-7718, 1994.
18. Nonaka I, Sunohara N, Ishiura S, Satoyoshi E. Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation. J Neurol Sci 51: 141-155, 1981.
19. Dubowitz V, Muscle Biopsy: a Practical Approach. Bailliere Tindall, London, 1985: 19-40.
20. Temparis S,Asensi M, Taillandier D, et al. Increased ATP-ubiquitin dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res 54: 5568-5573, 1994.
21. Goll DE, Kleese WC, Szpacenko A. Skeletal muscle proleinases and protein turnover, in: Animal Growth Regulation, Campion DR, Hausman GJ, Martin RJ, Eds. Plenum Publishing, New York. 1989: 141-182.
22. Kar NC, Pearson CM. A calcium-activated neutral protease in normal and dystrophic human muscle. Clin Chim Acta 73: 293-297, 1976.
23. Kumamoto T, Ueyama H, Watanabe S, et al. Immunohistochemical study of calpain and its endogenous inhibitor in the skeletal muscle of muscular dystrophy. Acta Neuropathol (Berl) 89: 399-403, 1995.
24. Kumamoto T, Ueyama H, Sugihara R, Kominami E, Goll DE, Tsuda T. Calpain and cathepsins in the skeletal muscle of inflammatory myopathies. Eur Neurol 37: 176-181, 1997.
25. Koohmaraie M. Ovine skeletal muscle multicatalytic proteinase complex (proteasome): Purification, characterization, and comparison of its effects on myofibrils with mu-calpains. J Anim Sci 70: 3697-3708, 1992.
26. Cuervo AM, Palmer A, Rivett AJ, Knecht E. Degradation of proteasomes by lysosomes in rat liver. Eur J Biochem 227: 792-800, 1995.